Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 1,280 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Pathogen Transmission, Patient Participation, Aging
Interventions: Clean Hands Accessible and Manageable for Patients; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 65 Years and older
Enrollment: 293 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: COVID-19
Interventions: AZD3152, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Anniston, Alabama • Cullman, Alabama • Scottsdale, Arizona + 1 more

Conditions: Surgical Site Infection
Interventions: Air Barrier System; Device
Lead sponsor: Nimbic Systems, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV Infections
Interventions: Zidovudine; Drug
Lead sponsor: Glaxo Wellcome; Industry
Eligibility: 13 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: HIV, STI
Interventions: PrEP discontinuation intervention, Offering of on-demand oral PrEP, Offering of STI PEP, Injectable PrEP; Behavioral · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Covid19
Interventions: Facebook Ads on the importance of staying safe during the Thanksgiving / Christmas holiday; Behavioral
Lead sponsor: National Bureau of Economic Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 820 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: HIV-1 Infection, HIV Infection, Healthy Volunteers
Interventions: DCVax-001, Poly-ICLC, Placebo; Drug
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Operative Surgical Site Infection
Interventions: Standard of care, Vancomycin and Tobramycin; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 64 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 31
States / cities: Redwood City, California • San Francisco, California • Aurora, Colorado + 25 more

Conditions: HIV Infections
Interventions: Health Access Coalitions, Social Media, Peer Support, Promoting Human Autonomy Support & Empathy (PHASE); Behavioral
Lead sponsor: HIV Prevention Trials Network; Network
Eligibility: 15 Years and older · Male only
Enrollment: 2,700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV Seropositivity
Interventions: Computer-based simulation training for providers, Best Practice Alert, HIV Risk Assessment, PrEP Informational Video; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 1,380 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Urinary Tract Infection
Interventions: Nitrofurantoin, Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Human Immunodeficiency Virus
Interventions: Navigators (peer navigator) training, delayed-intervention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Male only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: West Nile Fever
Interventions: ChimeriVax-WN02 Low Dose, ChimeriVax-WN02 Medium Dose, ChimeriVax-WN02 High Dose, 0.9% Saline solution, 0.9 % NaCl solution; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 18 Years and older
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 5
States / cities: Phoenix, Arizona • Idaho Falls, Idaho • Lenexa, Kansas + 2 more

Conditions: HIV/AIDS, Gender, Behavior and Behavior Mechanisms
Interventions: PrEP Demonstration Project; Behavioral
Lead sponsor: Hektoen Institute for Medical Research; Other
Eligibility: 15 Years to 24 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV Infections, Histoplasmosis
Interventions: Itraconazole; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1994
U.S. locations: 12
States / cities: Los Angeles, California • Chicago, Illinois • Indianapolis, Indiana + 9 more

Conditions: H. Pylori Infection
Interventions: Test-and-treat EHR-CHW intervention, Usual care of EHR-only intervention; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV Infections
Interventions: Lamivudine/zidovudine, Efavirenz, Raltegravir; Drug
Lead sponsor: Westat; Other
Eligibility: 16 Years and older · Female only
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 4
States / cities: Fort Lauderdale, Florida • New Orleans, Louisiana • Memphis, Tennessee + 1 more

Conditions: Hiv
Interventions: decision aid; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: HIV Infections
Interventions: SAIA-HIV-SSP; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: COVID-19 Prevention
Interventions: Q-Griffithsin, Placebo; Drug · Other
Lead sponsor: Kenneth Palmer; Other
Eligibility: 18 Years to 60 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Post-Op Infection
Interventions: Metronidazole Vaginal; Drug
Lead sponsor: New York Medical College; Other
Eligibility: 18 Years and older · Female only
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: New York, New York • Valhalla, New York

Conditions: Sexual Transmission of Infection
Interventions: HIV prevention intervention, Diet and Nutrition; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 16 Years to 29 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: HIV, STI, Emotional Disturbances, Mental Disorder
Interventions: HIV/STI Prevention Intervention, General Health Control Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 14 Years to 17 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections
Interventions: Hey, Friend; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 14 Years to 18 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Clean Hands Accessible and Manageable for Patients (CHAMPs)

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Air Barrier System for the Prevention of Surgical Site Infection

A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus

Parrying the Pitfalls of PrEP: Project PEACH

The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign

DCVax Plus Poly ICLC in Healthy Volunteers

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Getting to Zero Among HHI MSM in the American South

A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP)

Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)

Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM)

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project

A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Patient-Centered Cancer Prevention In Chinese Americans

Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services Programs

PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray

PROJECT PREVENT: Metronidazole Antibiotic Per Vagina Before Hysterectomy: Is Additional Antibiotic Prophylaxis Beneficial?

HIV Prevention Intervention for Young Transgender Women

HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)

HIV Prevention and PrEP Intervention for SGM Adolescents and Parents: "Hey, Friend"